ATOS
Atossa Therapeutics, Inc.
$2.45
-0.04 (-1.61%)
At close · Jul 8
Market Cap
$21.10M
Shares
8,611,361
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-11 | 2026-06-10 | |
| 8-K | 2026-05-08 | 2026-05-07 | |
| 8-K | 2026-05-08 | — | |
| 10-Q | 2026-05-08 | 2026-03-31 | |
| 8-K | 2026-04-16 | 2026-04-13 | |
| DEF 14A | 2026-03-30 | — | |
| 8-K | 2026-03-25 | — | |
| 10-K | 2026-03-25 | 2025-12-31 | |
| 8-K | 2026-02-20 | 2026-02-19 | |
| 8-K | 2026-02-17 | — | |
| 8-K | 2026-02-11 | — | |
| 8-K | 2026-01-26 | 2026-01-20 | |
| 8-K | 2026-01-09 | — | |
| 8-K | 2026-01-06 | — | |
| DEF 14A | 2025-12-22 | 2025-12-19 | |
| 8-K | 2025-12-04 | — | |
| 8-K | 2025-11-12 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-10-14 | — | |
| 8-K | 2025-09-26 | — | |
| 8-K | 2025-09-08 | — | |
| 8-K | 2025-08-21 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-12 | — | |
| 8-K | 2025-05-13 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| 8-K | 2025-05-12 | 2025-05-08 | |
| 8-K | 2025-04-07 | — | |
| DEF 14A | 2025-03-26 | — | |
| 10-K | 2025-03-25 | 2024-12-31 | |
| 8-K | 2025-03-25 | — | |
| 8-K | 2025-03-12 | 2025-03-11 | |
| 8-K | 2025-02-24 | 2025-02-21 | |
| 8-K | 2025-02-04 | 2025-01-30 | |
| 8-K | 2024-12-10 | — | |
| 8-K | 2024-11-19 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-11-04 | — | |
| 8-K | 2024-08-12 | — | |
| 10-Q | 2024-08-12 | 2024-06-30 | |
| 8-K | 2024-07-02 | 2024-06-27 | |
| DEF 14A | 2024-05-23 | — | |
| 10-Q | 2024-05-13 | 2024-03-31 | |
| 8-K | 2024-05-13 | — | |
| 8-K/A | 2024-04-02 | 2024-04-01 | |
| 10-K | 2024-04-01 | 2023-12-31 | |
| 8-K | 2024-04-01 | — | |
| 8-K | 2024-03-18 | 2024-03-15 | |
| 8-K | 2024-03-12 | 2024-03-09 |
Showing 1–50 of 120 filings